Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 236

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice

Open access
Fressart, Veronique, Duthoit, Guillaume, Donal, Erwan, Probst, Vincent, Deharo, Jean-Claude, Chevalier, Philippe, Klug, Didier, Dubourg, Olivier, Delacretaz, Etienne, Cosnay, Pierre, Scanu, Patrice, Extramiana, Fabrice, Keller, Dagmar, Hidden-Lucet, Françoise, Simon, Françoise, Bessirard, Vanessa, Roux-Buisson, Nathalie, Hebert, Jean-Louis, Azarine, Arshid, Casset-Senon, Daniele, Rouzet, François, Lecarpentier, Yves, Fontaine, Guy, Coirault, Catherine, Frank, Robert, Hainque, Bernard, Charron, Philippe · 2010 · EP Europace

Abstract

AIMS: Five desmosomal genes have been recently implicated in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) but the clinical impact of genetics remains poorly understood. We wanted to address the potential impact of genotyping. METHODS AND RESULTS: Direct sequencing of the five genes (JUP, DSP, PKP2, DSG2, and DSC2) was performed in 135 unrelated patients with ARVD/C. We identified 41 different disease-causing mutations, including 28 novel ones, in 62 patients (46%). In addition, a genetic variant of unknown significance was identified in nine additional patients (7%). Distribution of genes was 31% (PKP2), 10% (DSG2), 4.5% (DSP), 1.5% (DSC2), and 0% (JUP). The presence of desmosomal mutations was not associated with familial context but was associated with young age, symptoms, electrical substrate, and extensive structural damage. When compared with other genes, DSG2 mutations were associated with more frequent left ventricular involvement (P = 0.006). Finally, complex genetic status with multiple mutations was identified in 4% of patients and was associated with more frequent sudden death (P = 0.047). CONCLUSION: This study supports the use of genetic testing as a new diagnostic tool in ARVC/D and also suggests a prognostic impact, as the severity of the disease appears different according to the underlying gene or the presence of multiple mutations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/europace/euq104

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 236

Metadata

Authors
Fressart, V., Duthoit, G., Donal, E., Probst, V., Deharo, J.-C., Chevalier, P., Klug, D., Dubourg, O., Delacretaz, E., Cosnay, P., Scanu, P., Extramiana, F., Keller, D., Hidden-Lucet, F., Simon, F., Bessirard, V., Roux-Buisson, N., Hebert, J.-L., Azarine, A., Casset-Senon, D., Rouzet, F., Lecarpentier, Y., Fontaine, G., Coirault, C., Frank, R., Hainque, B., & Charron, P.
Venue
EP Europace
Published
2010-04-16
Volume
12
Issue
6
Pages
861-868
ISSN
  • 1099-5129 (ISSN-L)
  • 1532-2092
OpenAlex
W2164869673
Cited by
236
References
1
FWCI
14.72
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. https://app.cochat.ai/papers/10.1093/europace/euq104
The paper
Fressart, V., Duthoit, G., Donal, E., Probst, V., Deharo, J.-C., Chevalier, P., Klug, D., Dubourg, O., Delacretaz, E., Cosnay, P., Scanu, P., Extramiana, F., Keller, D., Hidden-Lucet, F., Simon, F., Bessirard, V., Roux-Buisson, N., Hebert, J.-L., Azarine, A., . . . Charron, P. (2010). Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. EP Europace. https://doi.org/10.1093/europace/euq104

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.